These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

861 related items for PubMed ID: 12384537

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses.
    Hodge JW, Poole DJ, Aarts WM, Gómez Yafal A, Gritz L, Schlom J.
    Cancer Res; 2003 Nov 15; 63(22):7942-9. PubMed ID: 14633725
    [Abstract] [Full Text] [Related]

  • 5. Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity.
    Greiner JW, Zeytin H, Anver MR, Schlom J.
    Cancer Res; 2002 Dec 01; 62(23):6944-51. PubMed ID: 12460911
    [Abstract] [Full Text] [Related]

  • 6. Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas.
    Marshall JL, Gulley JL, Arlen PM, Beetham PK, Tsang KY, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J.
    J Clin Oncol; 2005 Feb 01; 23(4):720-31. PubMed ID: 15613691
    [Abstract] [Full Text] [Related]

  • 7. Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules.
    Tsang KY, Palena C, Yokokawa J, Arlen PM, Gulley JL, Mazzara GP, Gritz L, Yafal AG, Ogueta S, Greenhalgh P, Manson K, Panicali D, Schlom J.
    Clin Cancer Res; 2005 Feb 15; 11(4):1597-607. PubMed ID: 15746065
    [Abstract] [Full Text] [Related]

  • 8. Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.
    Kudo-Saito C, Schlom J, Hodge JW.
    Clin Cancer Res; 2005 Mar 15; 11(6):2416-26. PubMed ID: 15788693
    [Abstract] [Full Text] [Related]

  • 9. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
    Kass E, Panicali DL, Mazzara G, Schlom J, Greiner JW.
    Cancer Res; 2001 Jan 01; 61(1):206-14. PubMed ID: 11196163
    [Abstract] [Full Text] [Related]

  • 10. Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.
    Zhu M, Terasawa H, Gulley J, Panicali D, Arlen P, Schlom J, Tsang KY.
    Cancer Res; 2001 May 01; 61(9):3725-34. PubMed ID: 11325845
    [Abstract] [Full Text] [Related]

  • 11. A triad of costimulatory molecules synergize to amplify T-cell activation.
    Hodge JW, Sabzevari H, Yafal AG, Gritz L, Lorenz MG, Schlom J.
    Cancer Res; 1999 Nov 15; 59(22):5800-7. PubMed ID: 10582702
    [Abstract] [Full Text] [Related]

  • 12. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity.
    Hodge JW, McLaughlin JP, Abrams SI, Shupert WL, Schlom J, Kantor JA.
    Cancer Res; 1995 Aug 15; 55(16):3598-603. PubMed ID: 7543017
    [Abstract] [Full Text] [Related]

  • 13. Technology evaluation: CEA-TRICOM, Therion Biologics Corp.
    Morse MA.
    Curr Opin Mol Ther; 2001 Aug 15; 3(4):407-12. PubMed ID: 11525565
    [Abstract] [Full Text] [Related]

  • 14. Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules.
    Morse MA, Clay TM, Hobeika AC, Osada T, Khan S, Chui S, Niedzwiecki D, Panicali D, Schlom J, Lyerly HK.
    Clin Cancer Res; 2005 Apr 15; 11(8):3017-24. PubMed ID: 15837756
    [Abstract] [Full Text] [Related]

  • 15. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.
    Chakraborty M, Abrams SI, Coleman CN, Camphausen K, Schlom J, Hodge JW.
    Cancer Res; 2004 Jun 15; 64(12):4328-37. PubMed ID: 15205348
    [Abstract] [Full Text] [Related]

  • 16. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.
    Kass E, Schlom J, Thompson J, Guadagni F, Graziano P, Greiner JW.
    Cancer Res; 1999 Feb 01; 59(3):676-83. PubMed ID: 9973217
    [Abstract] [Full Text] [Related]

  • 17. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
    Tsang KY, Zhu M, Even J, Gulley J, Arlen P, Schlom J.
    Cancer Res; 2001 Oct 15; 61(20):7568-76. PubMed ID: 11606396
    [Abstract] [Full Text] [Related]

  • 18. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
    McLaughlin JP, Schlom J, Kantor JA, Greiner JW.
    Cancer Res; 1996 May 15; 56(10):2361-7. PubMed ID: 8625312
    [Abstract] [Full Text] [Related]

  • 19. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
    Zeytin HE, Patel AC, Rogers CJ, Canter D, Hursting SD, Schlom J, Greiner JW.
    Cancer Res; 2004 May 15; 64(10):3668-78. PubMed ID: 15150127
    [Abstract] [Full Text] [Related]

  • 20. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.